< Back to previous page

Publication

Correction to

Journal Contribution - Journal Article

Subtitle:A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

An amendment to this paper has been published and can be accessed via the original article.

Journal: Trials
ISSN: 1745-6215
Issue: 1
Volume: 21
Publication year:2020
Accessibility:Open